Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

被引：6
|
作者：
Sengler, C. [1 ]
Niewerth, M. [1 ]
Kallinich, T. [2 ]
Nimtz-Talaska, A.
Haller, M.
Huppertz, H. -I. [3 ]
Minden, K. [1 ]
机构：
[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, D-10117 Berlin, Germany
[2] Charite, Childrens Univ Hosp, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany
[3] Klinikum Bremen Mitte, Bremen, Germany
来源：
CLINICAL RHEUMATOLOGY | 2014年 / 33卷 / 01期
关键词：
Children; Disease activity; Flare; H1N1 influenza vaccination; Rheumatic disease; JUVENILE IDIOPATHIC ARTHRITIS; SAFETY; IMMUNOGENICITY;
D O I：
10.1007/s10067-013-2435-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The objective of this study is to evaluate complications and changes in health status (disease activity and flare) in response to the AS03-adjuvanted H1N1 vaccine in children with rheumatic diseases. We conducted a nationwide survey addressing paediatric rheumatology sites who participated in the national paediatric rheumatology database. Ninety patients were documented-38 % under treatment with biologicals-of whom 18 % suffered from complications (10 % local and 8 % systemic) with no relevant changes in median disease activity or flare rate during 4 weeks following the vaccination. The adjuvanted H1N1 influenza vaccine seems to be adequately tolerated in children with rheumatic diseases.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [41] Fetal Safety of an Adjuvanted Influenza A(H1N1)pdm09 Vaccine
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Svanstrom, Henrik
    Krause, Tyra G.
    Emborg, Hanne-Dorthe
    Melbye, Mads
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 392 - 392
  • [42] Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
    Mohty, Bilal
    Bel, Michael
    Vukicevic, Marija
    Nagy, Monika
    Levrat, Emmanuel
    Meier, Sara
    Grillet, Stephane
    Combescure, Christophe
    Kaiser, Laurent
    Chalandon, Yves
    Passweg, Jakob
    Siegrist, Claire-Anne
    Roosnek, Eddy
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06): : 896 - 904
  • [43] The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine
    Rubinstein, Ethan
    Predy, Gerald
    Sauve, Laura
    Hammond, Greg W.
    Aoki, Fred
    Sikora, Chris
    Li, Yan
    Law, Barbara
    Halperin, Scott
    Scheifele, David
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (13) : E1033 - E1037
  • [44] Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients
    Labriola, Laura
    Hombrouck, Anneleen
    Marechal, Celine
    Van Gucht, Steven
    Brochier, Bernard
    Thomas, Isabelle
    Jadoul, Michel
    Goubau, Patrick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1424 - 1428
  • [45] Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1) reply
    Hoschler, Katja
    Zambon, Maria
    Nicholson, Karl G.
    LANCET INFECTIOUS DISEASES, 2011, 11 (07): : 497 - 498
  • [46] Influenza H1N1 vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2009, 32 (06) : 166 - 166
  • [47] Influenza H1N1 vaccine
    Patounas, Marea
    McGuire, Treasure
    AUSTRALIAN PRESCRIBER, 2010, 33 (01) : 5 - 5
  • [48] Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine Two Open-label, Randomized Trials
    Vesikari, Timo
    Richardus, Jan Hendrik
    Berglund, Johan
    Korhonen, Tiina
    Flodmark, Carl-Erik
    Lindstrand, Ann
    Silfverdal, Sven Arne
    Bambure, Vinod
    Caplanusi, Adrian
    Dieussaert, Ilse
    Roy-Ghanta, Sumita
    Vaughn, David W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (07) : 774 - 782
  • [49] The antibody response of HSCT recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic
    Engelhard, D.
    Zakay-Rones, Z.
    Shapira, M. Y.
    Resnick, I. B.
    Grisariu, S.
    Averbuch, D.
    Dray, L.
    Bogorichin, B.
    Djian, E.
    Grotto, I.
    Wolf, D.
    Or, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S27 - S27
  • [50] Influenza A/H1N1 MF59 adjuvanted vaccine safe during pregnancy
    Reactions Weekly, 2013, 1441 (1) : 3 - 3
12345